Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242339 (
dyslipidemia
)
13,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Characterised by
abnormal breathing
during sleep, obstructive sleep apnea (OSA) is strongly associated with obesity. Visceral obesity is a component of metabolic syndrome with insulin resistance, hypertension and
dyslipidemia
. OSA may also represent an independent risk factor for cardiovascular disease, especially hypertension, diabetes mellitus and
dyslipidemia
. Abdominal adiposity is an important factor for the development of OSA and associated metabolic disorders. Diagnosis of metabolic syndrome can be made using usual markers like waist circumference, arterial pressure measurement, fasting blood glucose, fasting cholesterol, triglyceride and HDL-cholesterol. Those parameters should be systematically evaluated in case of OSA.
...
PMID:[Which complementary studies and metabolic monitoring must be performed in OSAS? For which patients?]. 1978 52